New shot could tame tough eczema in phase 2 trial
NCT ID NCT07211542
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 30 times
Summary
This study tests an experimental drug called SHR-1905 for adults with moderate-to-severe atopic dermatitis (eczema). About 75 participants will receive either the drug or a placebo injection to see if it safely reduces skin redness, itching, and rash. The main goal is to check if eczema severity drops by at least 75% after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dermatology Hospital of Southern Medical University
RECRUITINGGuangzhou, Guangdong, 510091, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.